LH — Labcorp Holdings Inc. stock price, charts and financials

QT67Labcorp Holdings Inc.

Labcorp Holdings Inc. (NYSE: LH) is a Healthcare company in the Medical - Diagnostics & Research industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
320.67
+1.49+0.47%
OverviewShort InterestFilings
LHQT67Labcorp Holdings Inc.·NYSE
320.67+0.47%
TA
Loading chart...
Signal & projected range
Insider selling clusterHistorical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Premium shows the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
DGX-0.18%$237.92ILMN+1.56%$190.90MTD+0.68%$1439.17GH+0.58%$169.46WAT+0.69%$409.66IQV+1.45%$242.15A+1.53%$148.21MEDP+1.01%$596.63
Snapshot
IndexS&P 500P/E26.23EPS (ttm)12.17Insider Own0.52%Shs Outstand82.00MPerf Week3.22%
Market Cap26.17BForward P/E16.14EPS next Y19.78Insider Trans-6.79%Shs Float81.67MPerf Month14.96%
Enterprise Value32.80BPEG0.79EPS next Q4.60Inst Own-Short Float3.33%Perf Quarter23.69%
Income1.01BP/S1.82EPS this Y51.02%Inst Trans-Short Ratio4.15Perf Half Y14.71%
Sales14.35BP/B3.03EPS next Y8.34%ROA5.41%Short Interest2.72MPerf YTD27.22%
Book/sh-P/C15.92EPS next 5Y8.11%ROE11.57%52W High321.44 -0.24%Perf Year22.36%
Cash/sh-P/FCF22.66EPS past 3/5Y-9.17% -8.01%ROIC7.93%52W Low245.66 30.53%Perf 3Y48.49%
Dividend Est.2.88 (0.90%)EV/EBITDA15.24Sales past 3/5Y5.55% -0.04%Gross Margin27.85%Volatility2.21% 2.96%Perf 5Y25.45%
Dividend TTM2.88 (0.90%)EV/Sales2.29EPS Y/Y TTM36.76%Oper. Margin11.27%ATR (14)8.50Perf 10Y168.23%
Dividend Ex-DateAug 28, 2026Quick Ratio1.53Sales Y/Y TTM10.30%Profit Margin6.99%RSI (14)71.54Recom2.26
Dividend Gr. 3/5Y15.78% -Current Ratio1.80EPS Q/Q14.71%SMA207.53%Beta0.86Target Price319.33
Payout23.86%Debt/Eq0.79Sales Q/Q5.78%SMA5014.12%Rel Volume0.62Prev Close319.17
Employees71,000LT Debt/Eq0.75EarningsOct 27SMA20018.65%Avg Volume673.09KPrice320.67
IPO DateMar 29, 1990Option/ShortYes / YesEPS/Sales Surpr.4.41% 0.59%Net Debt/EBITDA3.08Volume419,607Change0.47%
Analyst Ratings
DateActionAnalystRatingTarget
Jul-31-26ReiteratedDeutsche BankHold$276 → $306
Jul-31-26ReiteratedRobert W. Baird$338 → $352
Jul-31-26ReiteratedMorgan StanleyOverweight$303 → $338
May-01-26ReiteratedRobert W. Baird$332 → $334
Apr-08-26ReiteratedEvercore ISI GroupOutperform$305 → $300
Feb-24-26ReiteratedPiper SandlerNeutral$300
Feb-18-26ReiteratedRobert W. Baird$313 → $326
Jan-14-26ReiteratedRobert W. Baird$307 → $313
Oct-29-25ReiteratedRobert W. Baird$313 → $304
Oct-29-25ReiteratedUBSBuy$325 → $320
Latest News
Today
Today11:45AM
Is Labcorp Stock a Buy as Growth Improves but Valuation Stays Rich?zacks.com
10:50AM
Here's Why Labcorp Holdings (LH) is a Strong Momentum Stockzacks.com
07:00AM
Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanomaprnewswire.com
Aug-07-26
Aug-07-2611:41AM
Labcorp Stock Jumps 14% in a Month as Growth Meets Rich Valuationzacks.com
Aug-04-26
Aug-04-2601:55PM
OPKO Health: Mazdutide And MDX-2201 Could Change EverythingSeekingAlpha
10:41AM
Here's Why Labcorp Holdings (LH) is a Strong Value Stockzacks.com
07:00AM
Labcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancerprnewswire.com
Jul-31-26
Jul-31-2608:04AM
Labcorp Q2 Earnings Call Highlightsmarketbeat.com
Jul-30-26
Jul-30-2602:43PM
Labcorp Holdings Inc. (LH) Q2 2026 Earnings Call Transcriptseekingalpha.com
12:31PM
LH Stock Down Despite Q2 Earnings and Revenue Beat, Margins Risezacks.com
10:31AM
Labcorp (LH) Reports Q2 Earnings: What Key Metrics Have to Sayzacks.com
09:06AM
Labcorp Holdings (LH) Surpasses Q2 Earnings and Revenue Estimateszacks.com
08:27AM
Labcorp raises annual profit forecast on strong testing demandreuters.com
06:50AM
Labcorp Announces 2026 Second Quarter Results; Raises Full Year 2026 Guidanceprnewswire.com
Jul-29-26
Jul-29-2610:16AM
Labcorp (LH) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimateszacks.com
Company

Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue14,34913,95213,009——————
Cost of Goods Sold Incl. D&A10,35110,2199,385——————
Gross Profit3,9963,7333,624——————
Selling, General and Administrative Excl. Other2,2192,2162,230——————
Research and Development
000——————
Other Operating Expense1600308——————
Operating Income1,6181,5161,087——————
Interest Expense227224208——————
Unusual Expense
—————————
Non-Operating Income (Expense)-156-18581——————
Net Income Before Taxes1,2341,108960——————
Income Taxes231230212——————
Consolidated Net Income1,003877746——————
Net Income From Continuing Operations1,004878747——————
Net Income1,003877746——————
EPS (Recurring)12.1710.548.89——————
EPS (Basic, Before Extraordinaries)12.1710.548.89——————
EPS (Diluted)12.0910.468.84——————
EBITDA2,1522,0131,811——————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio26.5223.9825.94——————
Price To Sales Ratio1.831.491.48——————
Gross Margin27.8526.7627.86——————
Operating Margin11.2810.878.36——————
Net Margin6.996.295.73——————
Shares Outstanding828384——————
Market Capitalization26,29520,82319,263——————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
$330.59$305.85$281.11$256.36$231.62● Close Price0.00M0.77M1.55M2.32M3.10MUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Summy Amy B.EVP, Chief Marketing OfficerAug 04 '26Sale306.74924283,4286,956Aug 06
Wilkinson Peter JSVP, Chief Accounting OfficerAug 03 '26Option Exercise209.251,338279,9773,108Aug 05
Wilkinson Peter JSVP, Chief Accounting OfficerAug 03 '26Sale309.231,420439,1071,770Aug 05
Vaughn Bryan TEVP and President, DiagnosticsJul 02 '26Sale286.1923466,9686,746Jul 06
Kyle Kathryn WEVP, Chief Legal OfficerJul 02 '26Sale286.199226,3293,904Jul 06
Kyle Kathryn WEVP, Chief Legal OfficerJul 01 '26Option Exercise0.0025604,069Jul 06
Vaughn Bryan TEVP and President, DiagnosticsJul 01 '26Option Exercise0.0032707,073Jul 06
Kyle Kathryn WEVP, Chief Legal OfficerJun 08 '26Sale263.89762201,0843,813Jun 10
Schechter Adam HPresident & CEOMay 11 '26Sale254.505,9031,502,314107,234May 13
Wilkinson Peter JSVP, Chief Accounting OfficerMar 27 '26Sale267.051,633436,0931,852Mar 30
Meltzer Jonathan CEVP, OperationsMar 27 '26Sale267.05839224,0553,620Mar 30
Schechter Adam HPresident & CEOMar 03 '26Sale279.968,7052,437,04780,773Mar 05
van der Vaart Sandra DEVP, Corporate AffairsFeb 27 '26Sale284.91548156,0002,579Mar 03
Caveney Brian JEVP, Pres of ED, CMO & CSOFeb 24 '26Sale286.311,500429,45830,107Feb 26
Wilkinson Peter JSVP, Chief Accounting OfficerFeb 19 '26Sale277.94666185,1081,852Feb 23
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.